• 1.

    Koch Hein EC, et al. Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world experience from a Canadian comprehensive cancer centre. Cancers 2023; 15:4312. doi: 10.3390/cancers15174312

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Carroll RP, et al. Immune checkpoint inhibitors in kidney transplant recipients: A multicentre, single-arm, phase 1 study. Lancet Oncol 2022; 23:10781086. doi: 10.1016/S1470-2045(22)00368-0

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Barnett R, et al. Preserved renal-allograft function and the PD-1 pathway inhibitor nivolumab. N Engl J Med 2017; 376:191192. doi: 10.1056/NEJMc1614298

  • 4.

    Schenk KM, et al. Nivolumab + tacrolimus + prednisone ± ipilimumab for kidney transplant recipients with advanced cutaneous cancers. J Clin Oncol 2024; 42:10111020. doi: 10.1200/JCO.23.01497

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Hanna GJ, et al. Cemiplimab for kidney transplant recipients with advanced cutaneous squamous cell carcinoma. J Clin Oncol 2024; 42:10211030. doi: 10.1200/JCO.23.01498

    • PubMed
    • Search Google Scholar
    • Export Citation

mTOR Inhibitors and Pulsed Steroid Regimen in Kidney Transplant Recipients Undergoing Immune Checkpoint Inhibitor Therapy for Advanced Cutaneous Malignancies: The Key Toward Maximizing Efficacy and Mitigating Rejection

Rose Mary Attieh Rose Mary Attieh, MD, is the Galdi Fellow in Onco-Nephrology and Glomerular Diseases at Northwell Health, and Kenar D. Jhaveri, MD, FASN, is professor of medicine and an attending nephrologist at Northwell Health in New Hyde Park, NY, and is editor-in-chief of Kidney News. Hani M. Wadei, MD, FASN, is a transplant nephrology specialist and professor of medicine at the Mayo Clinic, Jacksonville, FL.

Search for other papers by Rose Mary Attieh in
Current site
Google Scholar
PubMed
Close
,
Kenar D. Jhaveri Rose Mary Attieh, MD, is the Galdi Fellow in Onco-Nephrology and Glomerular Diseases at Northwell Health, and Kenar D. Jhaveri, MD, FASN, is professor of medicine and an attending nephrologist at Northwell Health in New Hyde Park, NY, and is editor-in-chief of Kidney News. Hani M. Wadei, MD, FASN, is a transplant nephrology specialist and professor of medicine at the Mayo Clinic, Jacksonville, FL.

Search for other papers by Kenar D. Jhaveri in
Current site
Google Scholar
PubMed
Close
, and
Hani M. Wadei Rose Mary Attieh, MD, is the Galdi Fellow in Onco-Nephrology and Glomerular Diseases at Northwell Health, and Kenar D. Jhaveri, MD, FASN, is professor of medicine and an attending nephrologist at Northwell Health in New Hyde Park, NY, and is editor-in-chief of Kidney News. Hani M. Wadei, MD, FASN, is a transplant nephrology specialist and professor of medicine at the Mayo Clinic, Jacksonville, FL.

Search for other papers by Hani M. Wadei in
Current site
Google Scholar
PubMed
Close
Restricted access
Save